| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $77.48M | $60.37M | $36.35M | $163.35M | $46.15M |
| R&D | – | – | – | – | – |
| SG&A | $15.71M | $14.65M | $21.40M | $22.88M | $10.39M |
| Operating Income | – | – | – | – | – |
| Interest Expense | $31.94M | $25.18M | $22.70M | $21.32M | $14.27M |
| Tax Expense | $468.00K | -$10.66M | $10.66M | $0.00 | $0.00 |
| Net Income | -$76.88M | -$15.24M | $1.29B | -$93.57M | -$38.49M |
| EPS (basic) | -0.4700 | -0.0900 | 8.2900 | -0.7000 | -0.3200 |
| EPS (diluted) | -0.4700 | -0.0900 | 8.0200 | -0.7000 | -0.3200 |
| Shares (diluted) | $162.17M | $161.34M | $160.63K | $133.71M | $118.81M |